SixMap
Venture Round in 2025
SixMap is an information technology company focused on enhancing cybersecurity through its external attack surface management platform. This technology is designed to detect and remediate vulnerabilities in network security policies by providing insights into the network's attack surfaces from an attacker's perspective. By enabling organizations to monitor their security posture effectively, SixMap assists in planning and managing transitions during cyber incidents, thereby reinforcing overall network security. The company's expertise lies in network security, software development, and cybersecurity, positioning it as a key player in the defense against cyber threats.
MIIST Therapeutics
Seed Round in 2025
MIIST Therapeutics focuses on advancing pulmonary drug delivery systems and digital platforms to improve inhaled drug therapies. The company is developing innovative technology aimed at facilitating smoking cessation and addressing the health risks associated with tobacco use. By creating inhaler technology that targets the deepest areas of the lungs, MIIST enables rapid absorption of medications. This approach aims to enhance the effectiveness of inhaled treatments for various health conditions, starting with smoking addiction, and ultimately seeks to reduce the significant health burdens related to tobacco consumption.
Catena Biosciences
Seed Round in 2024
Catena Biosciences is a biotechnology firm focused on advancing protein conjugation technology to address autoimmune disorders and other medical challenges. The company specializes in a method that facilitates the rapid and selective attachment of proteins, utilizing natural amino acids such as tyrosine and cysteine. This innovative approach allows researchers to develop novel therapeutics across various fields, including autoimmune disorders, oncology, and vaccine development. By streamlining the process of building biologic structures, Catena Biosciences aims to enhance medical research and contribute to the creation of effective treatments.
FreeWire Technologies, Inc. is a manufacturer of mobile electric vehicle (EV) chargers, focused on providing innovative charging solutions that enhance the accessibility of EV charging infrastructure. Established in 2014 and based in San Leandro, California, the company produces several models, including the Mobi Charger v0, v1, and v2, which cater to varying charging needs and capabilities. FreeWire’s flagship product, the Boost Charger, integrates battery technology with power conversion systems, allowing for high-power charging without the need for extensive grid upgrades. This technology enables ultrafast charging at locations that typically lack sufficient electrical infrastructure. FreeWire has successfully deployed its battery-integrated chargers across the United States, serving Fortune 100 companies, commercial clients, fleets, and retail spaces, and has partnered with major organizations to expand its reach. Additionally, the company's systems provide clean and quiet power solutions, effectively replacing or supplementing diesel generators for various remote power applications, thereby supporting the transition away from fossil fuels.
SixMap is an information technology company focused on enhancing cybersecurity through its external attack surface management platform. This technology is designed to detect and remediate vulnerabilities in network security policies by providing insights into the network's attack surfaces from an attacker's perspective. By enabling organizations to monitor their security posture effectively, SixMap assists in planning and managing transitions during cyber incidents, thereby reinforcing overall network security. The company's expertise lies in network security, software development, and cybersecurity, positioning it as a key player in the defense against cyber threats.
Windfall Data, established in 2016 and headquartered in San Francisco, specializes in determining the net worth of global households. The company provides actionable consumer financial data that is updated weekly, serving both nonprofit and for-profit organizations. This data helps over 400 organizations identify and engage their most valuable constituents. Windfall Data's platform utilizes various datasets and proprietary algorithms to offer insights for marketing, sales, and analytics, enabling businesses to prioritize consumers effectively. The company is supported by several venture capital firms including Bullpen Capital, Bonfire Ventures, Industry Ventures, TenOneTen Ventures, ValueStream Ventures, and Auren Hoffman.
Kyte is a technology and operations company founded in San Francisco in 2019 by Francesco Wiedemann, Ludwig Schoenack, and Nikolaus Volk. The company specializes in providing on-demand car rentals, delivering vehicles directly to customers' locations for various durations, ranging from a day to several months. Operating in over ten cities across the United States, Kyte is rapidly expanding its services. The platform not only facilitates convenient car delivery but also includes additional offerings such as car cleaning and refueling, allowing customers to enjoy the benefits of transportation without the commitment of owning a personal vehicle.
Engage Bio
Seed Round in 2022
Engage Bio is developing mRNA treatments that change cancer cells into production facilities for immunotherapies. With the help of these treatments, the immune system is activated and directed toward the tumour.
Synvivia
Venture Round in 2021
Synvivia, Inc. is a biotechnology company founded in 2016 and based in Berkeley, California. The company specializes in developing synthetic biology products, particularly ON-OFF switches for genetically engineered organisms. These protein switches are regulated by small molecules, allowing for precise control of biological functions within the organisms. Synvivia's innovations enable the creation of engineered organisms that can be utilized in healthcare, specifically for diagnosing diseases and enhancing treatment options. Additionally, the company is focused on generating biosensors to identify and improve enzymatic activities, thereby facilitating more effective disease management.
Calyx specializes in developing advanced sensor technology focused on monitoring environmental parameters, particularly in the poultry and livestock sectors. The company integrates artificial intelligence, computer vision, and bio-engineered sensors to create versatile platforms capable of detecting airborne chemical emissions with high specificity and sensitivity. Its innovative sensors are designed using patterned viruses that bind to specific gas molecules, allowing for accurate detection of various airborne chemicals. This technology not only addresses complex challenges in livestock management but also enables commercial customers to monitor and respond to daily environmental health changes effectively.
Selva Therapeutics
Series A in 2020
Selva Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for infectious diseases. Founded in 2017 and based in San Diego, California, the company specializes in innovative antiviral solutions. Its lead product, SLV213, is an orally available small molecule that targets a wide range of viruses, including SARS-CoV-2, Ebola, and Nipah viruses, as well as addressing Chagas disease. This therapeutic has the potential to be used as a standalone treatment or in combination with other antiviral agents, providing healthcare institutions with effective options for managing significant global health threats.
Catena Biosciences is a biotechnology firm focused on advancing protein conjugation technology to address autoimmune disorders and other medical challenges. The company specializes in a method that facilitates the rapid and selective attachment of proteins, utilizing natural amino acids such as tyrosine and cysteine. This innovative approach allows researchers to develop novel therapeutics across various fields, including autoimmune disorders, oncology, and vaccine development. By streamlining the process of building biologic structures, Catena Biosciences aims to enhance medical research and contribute to the creation of effective treatments.